Measles, Mumps, Rubella And Varicella Virus Vaccine Live
Recommended VaccinesUnrestrictedNot applicable line
Immunisation of children aged 18 months against measles, mumps, rubella and varicella virus infection, as part of the National Immunisation Program.
1
Submissions
2012–12
On the record
—
ICER range
Cost-min
Cost basis
Access path
- Nov 2012Recommended
vs Priorix-Tetra
- PBS listing · Unrestricted
RecommendedDeferredNot recommended
Cost-effectiveness
Cost-minimisation analysis; no ICER calculated.
A cost-minimisation analysis was presented based on the non-inferiority claim around immunogenicity outcomes following vaccine administration. PBAC · 2012
Decision context
PopulationChildren aged 18 months receiving routine measles, mumps, rubella and varicella vaccination as part of the National Immunisation Program.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Nov 2012 | Recommended | Priorix-Tetra | — | RCT |